NEOPRISM-CRC
University College, London
University College, London
Merck Sharp & Dohme LLC
Teclison Ltd.
M.D. Anderson Cancer Center
University of Pittsburgh
Genentech, Inc.
Exelixis
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
AstraZeneca
Seagen Inc.
Vividion Therapeutics, Inc.
Tvardi Therapeutics, Incorporated
Tango Therapeutics, Inc.
Verastem, Inc.
Alnylam Pharmaceuticals
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Jazz Pharmaceuticals
Hoosier Cancer Research Network
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Merck Sharp & Dohme LLC
Washington University School of Medicine
Vividion Therapeutics, Inc.
CHA University
Daiichi Sankyo
PMV Pharmaceuticals, Inc
Mayo Clinic
University of California, Irvine
Sutro Biopharma, Inc.
National Institutes of Health Clinical Center (CC)
Neonc Technologies, Inc.
Shanghai Henlius Biotech
Pfizer
Dana-Farber Cancer Institute
AstraZeneca
Seagen Inc.
Tizona Therapeutics, Inc
Essen Biotech
Amsterdam UMC, location VUmc
Amgen
IDEAYA Biosciences
H. Lee Moffitt Cancer Center and Research Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
RemeGen Co., Ltd.
Eli Lilly and Company
M.D. Anderson Cancer Center